Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies

Barriers to Primary Care Physicians Prescribing Buprenorphine

(2014) E. Hutchinson et al.   ANNALS OF FAMILY MEDICINE

Use of Buprenorphine for Addiction Treatment: Perspectives of Addiction Specialists and General Psychiatrists

(2014) Cindy Parks Thomas et al.   PSYCHIATRIC SERVICES

Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone

(2013) Richard N. Rosenthal et al.   ADDICTION

Primary care patient characteristics associated with completion of 6-month buprenorphine treatment

(2013) Anne M. Neumann et al.   ADDICTIVE BEHAVIORS

Buprenorphine Use in Pregnant Opioid Users: A Critical Review

(2013) Michael Soyka   CNS DRUGS

Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study

(2013) Jessica A. Dreifuss et al.   DRUG AND ALCOHOL DEPENDENCE

Root Causes, Clinical Effects, and Outcomes of Unintentional Exposures to Buprenorphine by Young Children

(2013) Eric J. Lavonas et al.   JOURNAL OF PEDIATRICS

An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans

(2013) Richard C Crist et al.   NEUROPSYCHOPHARMACOLOGY

Reductions in prescription opioid diversion following recent legislative interventions in Florida

(2013) Hilary L. Surratt et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females

(2013) T-K Clarke et al.   PHARMACOGENOMICS JOURNAL

Association between gene variants and response to buprenorphine maintenance treatment

(2013) Gilberto Gerra et al.   PSYCHIATRY RESEARCH

Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment

(2013) R. Douglas Bruce et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Twelve-year trend in treatment seeking for buprenorphine abuse in Finland

(2012) Hanna Uosukainen et al.   DRUG AND ALCOHOL DEPENDENCE

Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial

(2012) Andrew J. Saxon et al.   DRUG AND ALCOHOL DEPENDENCE

Low absolute bioavailability of oral naloxone in healthy subjects

(2012) Kevin Smith et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Extent of illicit drug use and dependence, and their contribution to the global burden of disease

(2012) Louisa Degenhardt et al.   LANCET

Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?

(2012) Liza M. Reifler et al.   PAIN MEDICINE

Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners

(2012) Sandra A. Springer et al.   PLoS One

A Buprenorphine Education and Training Program for Primary Care Residents: Implementation and Evaluation

(2012) Hillary V. Kunins et al.   Substance Abuse

Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine

(2011) Daniel P. Alford et al.   ARCHIVES OF INTERNAL MEDICINE

Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir

(2011) V. A. Gruber et al.   CLINICAL INFECTIOUS DISEASES

Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians

(2011) Chris-Ellyn Johanson et al.   DRUG AND ALCOHOL DEPENDENCE

Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

(2011) David A Fiellin et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics

(2011) P Todd Korthuis et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

(2011) Frederick L Altice et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

A History of Being Prescribed Controlled Substances and Risk of Drug Overdose Death

(2011) Leonard J. Paulozzi et al.   PAIN MEDICINE

Unobserved versus observed office buprenorphine/naloxone induction: A pilot randomized clinical trial

(2010) Erik W. Gunderson et al.   ADDICTIVE BEHAVIORS

Buprenorphine Implants for Treatment of Opioid Dependence

(2010) Walter Ling et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Psychiatrist Characteristics That Influence Use of Buprenorphine Medication-Assisted Treatment

(2010) Joann Albright et al.   Journal of Addiction Medicine

Open-label dose-finding trial of buprenorphine implants (Probuphine)® for treatment of heroin dependence

(2009) Jason White et al.   DRUG AND ALCOHOL DEPENDENCE

Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy

(2009) T.V. Parran et al.   DRUG AND ALCOHOL DEPENDENCE

Acute liver and renal failure during treatment with buprenorphine at therapeutic dose

(2008) M. Zuin et al.   DIGESTIVE AND LIVER DISEASE

Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth

(2008) George E. Woody et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Home Buprenorphine/Naloxone Induction in Primary Care

(2008) Joshua D. Lee et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study

(2008) Declan T. Barry et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers

(2008) Alexander Y. Walley et al.   JOURNAL OF GENERAL INTERNAL MEDICINE